Hereditary Transthyretin Amyloidosis in Eight Chinese Families
Overview
Affiliations
Background: Mutations of transthyretin (TTR) cause the most common type of autosomal-dominant hereditary systemic amyloidosis, which occurs worldwide. To date, more and more mutations in the TTR gene have been reported. Some variations in the clinical presentation are often observed in patients with the same mutation or the patients in the same family. The purpose of this study was to find out the clinicopathologic and genetic features of Chinese patients with hereditary TTR amyloidosis.
Methods: Clinical and necessary examination materials were collected from nine patients of eight families with hereditary TTR amyloidosis at Peking University First Hospital from January 2007 to November 2014. Sural nerve biopsies were taken for eight patients and skin biopsies were taken in the calf/upper arm for two patients, for light and electron microscopy examination. The TTR genes from the nine patients were analyzed.
Results: The onset age varied from 23 to 68 years. The main manifestations were paresthesia, proximal and/or distal weakness, autonomic dysfunction, cardiomyopathy, vitreous opacity, hearing loss, and glossohypertrophia. Nerve biopsy demonstrated severe loss of myelinated fibers in seven cases and amyloid deposits in three. One patient had skin amyloid deposits which were revealed from electron microscopic examination. Genetic analysis showed six kinds of mutations of TTR gene, including Val30Met, Phe33Leu, Ala36Pro, Val30Ala, Phe33Val, and Glu42Gly in exon 2.
Conclusions: Since the pathological examinations of sural nerve were negative for amyloid deposition in most patients, the screening for TTR mutations should be performed in all the adult patients, who are clinically suspected with hereditary TTR amyloidosis.
Clinical phenotypes and genetic features of hereditary transthyretin amyloidosis patients in China.
He X, Tian Z, Guan H, Zhang S Orphanet J Rare Dis. 2022; 17(1):337.
PMID: 36056432 PMC: 9438301. DOI: 10.1186/s13023-022-02481-9.
Ophthalmological manifestations of hereditary transthyretin amyloidosis.
de Assis Aquino Gondim F, Holanda Filha J, Moraes Filho M Arq Bras Oftalmol. 2022; 85(5):528-538.
PMID: 35417510 PMC: 11826793. DOI: 10.5935/0004-2749.20220099.
Vagus nerve ultrasound in transthyretin familial amyloid polyneuropathy: A pilot study.
Du K, Xu K, Chu X, Tang Y, Lv H, Zhang W J Neuroimaging. 2021; 32(2):285-291.
PMID: 34964197 PMC: 9306858. DOI: 10.1111/jon.12956.
Skrahina V, Grittner U, Beetz C, Skripuletz T, Juenemann M, Kramer H Ann Med. 2021; 53(1):1787-1796.
PMID: 34658264 PMC: 8525987. DOI: 10.1080/07853890.2021.1988696.
Prevalence and Outcomes of p.Val142Ile Amyloidosis Cardiomyopathy: A Systematic Review.
Chandrashekar P, Alhuneafat L, Mannello M, Al-Rashdan L, Kim M, Dungu J Circ Genom Precis Med. 2021; 14(5):e003356.
PMID: 34461737 PMC: 8530896. DOI: 10.1161/CIRCGEN.121.003356.